Ultrasound-Guided Quadro-Iliac Plane Block for Pain Management After Total Hip Arthroplasty
Pain Management · Total Hip Arthroplasty
What this study involves
The registry says this study is recruiting. Individual locations may have different availability.
- Study type
- Interventional
- Phase
- Not applicable
- Age range
- 18 years - 80 years
- Sex eligible
- All sexes
- Healthy volunteers
- Not accepted
- Participants
- 100 Estimated
These are starting points, not an eligibility decision. The research team must review the full requirements.
About the research
This prospective, randomized, double-blind study evaluates the analgesic effectiveness of the ultrasound-guided Quadro-Iliac Plane (QIP) block in patients undergoing primary total hip arthroplasty. The QIP block is a recently described fascial plane block. Patients will be randomized to receive either a QIP block with local anesthetic or a sham block with saline. The primary outcome is 24-hour opioid consumption. Secondary outcomes include motor block, dermatomal sensory assessment, pain scores, rescue analgesic requirement, quality of recovery (QoR-15), and opioid-related side effects.
Read the full description
Total hip arthroplasty is associated with significant postoperative pain. The Quadro-Iliac Plane (QIP) block is a recently described fascial plane block targeting the area where the quadratus lumborum muscle attaches to the iliac crest and may provide more comprehensive analgesia. This study is designed as a prospective, randomized, double-blind clinical trial including patients aged 18-80 years with ASA physical status I-III undergoing elective primary total hip arthroplasty.
Patients will be randomized into two groups. The QIP group will receive an ultrasound-guided QIP block with 40 mL of 0.25% local anesthetic solution containing epinephrine, and the control group will receive a sham block with 40 mL of 0.9% NaCl using the same technique. The primary outcome is postoperative 24-hour opioid consumption. Secondary outcomes include motor block, and dermatomal sensory assessment, pain scores, quality of recovery (QoR-15), rescue analgesic requirement and opioid-related side effects
Who may be able to participate?
The list below is the sponsor’s full registry wording. It can include conditions, prior treatment, test results and other requirements. A match in search does not mean you qualify.
Inclusion Criteria:
- American Society of Anesthesiologists (ASA) classification I-III
- Age between 18 and 80 years
- Patients scheduled for elective primary total hip arthroplasty
Exclusion Criteria:
- Refusal to participate in the study
- Allergy to local anesthetics or opioids
- Known or suspected coagulopathy
- Infection at the injection site
- History of previous hip surgery
- Severe cardiovascular disease
- Liver or kidney failure
- Pregnancy, suspected pregnancy, or breastfeeding
- Severe neurological or psychiatric disorder
- Chronic opioid use
Treatment, groups and participation
The registry may describe treatments and study duration without a complete visit calendar. Ask the study team for the exact schedule, procedures, risks, costs and alternatives. Keep your usual care plan unless your treating clinician tells you otherwise.
- Assignment
- Random assignment
- Masking
- Quadruple masked
Quadro-Iliac Plane (QIP) Block
Participants in this arm will receive the standard analgesia protocol used for patients undergoing total hip arthroplasty. In addition to this standard regimen, an ultrasound-guided Quadro-Iliac Plane (QIP) block will be performed in the preoperative period with the patient in the lateral decubitus position. The technique aims to provide postoperative analgesia by achieving sensory blockade in the relevant dermatomal areas.
Procedure: Quadro-Iliac Plane (QIP) Block
Sham Block (Control)
Participants in this arm will receive the standard analgesia protocol used for patients undergoing total hip arthroplasty. In addition to this standard regimen, a sham block will be performed using the same ultrasound-guided technique and patient positioning to mimic the block procedure without providing active regional anesthesia.
Procedure: Sham Block
Quadro-Iliac Plane (QIP) Block PROCEDURE
An ultrasound-guided Quadro-Iliac Plane block performed in the preoperative period. At the level of the iliac crest, 40 mL of a solution containing 0.25% levobupivacaine and 5 µg/mL epinephrine is injected into the fascial plane between the erector spinae muscle and the quadratus lumborum muscle under aseptic conditions.
Sham Block PROCEDURE
A sham block performed using the same ultrasound-guided technique in the preoperative period. At the level of the iliac crest, 40 mL of 0.9% NaCl is injected into the fascial plane between the erector spinae muscle and the quadratus lumborum muscle under aseptic conditions.
What researchers are measuring
Outcome measures describe what is being studied. They are not proof that a treatment works.
Primary measures
Postoperative 24-Hour Morphine PCA Consumption
Time frame: Postoperative 24 hours
Total amount of morphine delivered by the patient-controlled analgesia (PCA) device during the first 24 hours after surgery, recorded in milligrams (mg).
Secondary measures
NRS Pain Scores at Rest and Movement
Time frame: 2, 6, 12, 24, and 48 hours postoperatively
Postoperative pain will be assessed using the Numeric Rating Scale (NRS), where 0 indicates no pain and 10 indicates the worst pain imaginable.
QoR-15 Recovery Score
Time frame: QoR-15 Recovery Score will be evaluated at the postoperative 48th hour
The investigators will use the Turkish version of Quality of Recovery (QoR) / QoR-15 questionnaire.
PART A How have you been feeling in the last 24 hours? (0 to 10, where: 0 = none of the time \[poor\] and 10 = all of the time \[excellent\])
Able to breathe easily Been able to enjoy food Feeling rested Have had a good sleep Able to look after personal toilet and hygiene unaided Able to communicate Getting support from hospital doctors and nurses Able to return to work or usual home activities Feeling comfortable and in control Having a feeling of general well-being
PART B Have you had any of the following in the last 24 hours? (10 to 0, where: 10 = none of the time \[excellent\] and 0 = all of the time \[poor\])
Moderate pain Severe pain Nausea or vomiting Feeling worried or anxious Feeling sad or depressed
\[Total score range: 0-150 points\]
Lower Extremity Muscle Strength Score
Time frame: Postoperative 6th and 12th hours
Postoperative lower extremity muscle strength will be assessed at the 6th postoperative hour using a 0-5 grading scale, where 0 indicates no muscle contraction and 5 indicates normal strength.
The scale is defined as follows:
0 = no muscle contraction
1. = muscle contraction present without joint movement
2. = movement without overcoming gravity
3. = movement against gravity without resistance
4. = movement against partial resistance
5. = movement against full resistance (normal strength)
Rescue Analgesic Requirement
Time frame: Postoperative 0-48 hours
Number of patients requiring rescue analgesia (IV meperidine 0.5 mg/kg) and total dose administered when NRS ≥ 4.
Opioid-Related Side Effects
Time frame: Postoperative 0-48 hours
Opioid-related side effects will be assessed postoperatively
Other opioid-related side effects, including pruritus, constipation, and somnolence, will be recorded as present or absent.
Review the complete result tables and limitations in the official record.
Open official results ↗Research locations (1)
The overall study status and a local site’s status can differ. Confirm that location’s availability before traveling.
1 locations
Bursa City HospitalBursa, Turkey (Türkiye)Recruiting
Study team and timeline
- Lead sponsor
- Bursa City Hospital
- Study start
- Mar 16, 2026 Actual
- Primary completion
- Nov 9, 2026 Actual
- Study completion
- Mar 15, 2027 Estimated
- First posted
- Feb 13, 2026 Actual
- Last updated
- Nov 10, 2026 Actual
Official study contacts
Official study title
Effectiveness of Ultrasound-Guided Quadro-Iliac Plane Block for Pain Management After Total Hip Arthroplasty: A Prospective Randomized Study
Ask Wellness Clinical Research
Your message goes to WCR, including when this study is run by another organization. WCR may offer general guidance but may not operate this trial, have access to its team or be able to enroll you.
Source: ClinicalTrials.gov API v2. Information is submitted by sponsors and investigators. NLM does not approve the safety or science of all listed studies. Registry disclaimer.
Retrieved: Nov 12, 2026 · Last registry update: Nov 10, 2026
